Nithya Desikan

2019

In 2019, Nithya Desikan earned a total compensation of $1.8M as Chief Commercial Officer at RHYTHM PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$145,117
Option Awards$1,286,061
Salary$379,063
Total$1,810,241

Desikan received $1.3M in option awards, accounting for 71% of the total pay in 2019.

Desikan also received $145.1K in non-equity incentive plan and $379.1K in salary.

Rankings

In 2019, Nithya Desikan's compensation ranked 6,419th out of 13,971 executives tracked by ExecPay. In other words, Desikan earned more than 54.1% of executives.

ClassificationRankingPercentile
All
6,419
out of 13,971
54th
Division
Manufacturing
2,424
out of 5,701
58th
Major group
Chemicals And Allied Products
885
out of 2,200
60th
Industry group
Drugs
750
out of 1,886
60th
Industry
Pharmaceutical Preparations
551
out of 1,398
61st
Source: SEC filing on April 29, 2020.

Desikan's colleagues

We found two more compensation records of executives who worked with Nithya Desikan at RHYTHM PHARMACEUTICALS in 2019.

2019

Keith Gottesdiener

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2019

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Executive Officer

News

In-depth

You may also like